Vertex Ventures HC
Amanda Chen is currently a Senior Associate at Vertex Ventures HC (VVHC), located in Boston, where she helps to execute investments in biotech.
Prior to VVHC, Amanda was Manager of Cell Therapy Development at Satellite Biosciences, playing a key role in cell therapy CMC and preclinical operations from tech transfer through Series A, which raised $110M from Polaris, Lightspeed, aMoon and others.
She was also a venture creation fellow in the 2020 Flagship Pioneering Fellowship class.
Amanda received her PhD in biological engineering from MIT, her MPhil in chemical engineering from University of Cambridge (Churchill College), and her BS in biomedical engineering (summa cum laude) from University of Rochester. Amanda was named to the Forbes 30 Under 30 – Science list in 2021.
This person is not in any teams
This person is not in any offices
Vertex Ventures HC
Vertex Ventures HC is part of a global venture fund network under Vertex Holdings. Vertex Ventures HC invests globally in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health, with ~$400 million of assets under management.